Group One Trading
LMNL

Group One Trading’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Group One Trading’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10
Closed -$33 – 8195
2022
Q4 		$33 Sell
10
-23
-70% -$105 ﹤0.01% 7104
2022
Q3 		$0 Sell
33
-6
-15% -$30 ﹤0.01% 8497
2022
Q2 		$0 Hold
39
– – ﹤0.01% 8771
2022
Q1 		$0 Sell
39
-30
-43% -$281 ﹤0.01% 8973
2021
Q4 		$1K Sell
69
-451
-87% -$6.76K ﹤0.01% 8067
2021
Q3 		$12K Buy
520
+247
+90% +$7.12K ﹤0.01% 7437
2021
Q2 		$11K Buy
+273
New +$11.9K ﹤0.01% 7492

Other funds holding LMNL

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Group One Trading's LMNL Position: Q1 2023 in Review

Group One Trading sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q1 2023, closing a stake of 10 shares — an estimated $33 sold.

Group One Trading first reported a position in LMNL in Q2 2021 and held it in 7 quarters. The position peaked at $12K in Q3 2021. 8 funds tracked by Wall St. Rank hold LMNL as of Q1 2023.

  • Group One Trading reported no remaining Liminal BioSciences Inc. Common Shares position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 10 Liminal BioSciences Inc. Common Shares shares in Q1 2023, an estimated $33.
  • Group One Trading first reported a position in Liminal BioSciences Inc. Common Shares in Q2 2021 and held it in 7 quarters.
  • Group One Trading's Liminal BioSciences Inc. Common Shares position peaked at $12K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.